Condensed Unaudited Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Statement [Abstract]
Revenues	$ 126,268	$ 101,463
Operating expenses:
Cost of revenues (excluding depreciation and amortization)	41,725	38,972
General and administrative expenses	53,349	19,132
Selling and marketing expenses	68,918	20,570
Research and development expenses	17,231	9,784
Depreciation and amortization	12,766	10,117
Acquisition related expenses	344	707
Restructuring expenses		287
Total operating expenses	194,333	99,569
(Loss) / Income from operations	(68,065)	1,894
Interest expense	1,298	2,961
Other expenses	5,273	1,284
Change in fair value of warrant and derivative liabilities		23,600
Total other expenses	6,571	27,845
Loss before income taxes	(74,636)	(25,951)
Income tax benefit	(2,599)	(1,577)
Net loss	(72,037)	(24,374)
Other comprehensive (loss) / income :
Foreign currency translation adjustment	(244)	54
Total comprehensive loss	(72,281)	(24,320)
Net loss per share
Net loss	(72,037)	(24,374)
Cumulative redeemable convertible preferred stock dividends		3,894
Net loss available to common stockholders	$ (72,037)	$ (28,268)
Basic loss per share	$ (0.54)	$ (0.86)
Diluted loss per share	$ (0.54)	$ (0.86)
Weighted average number of shares used to compute net loss per share
Basic	134,084,703	32,846,991
Diluted	134,084,703	32,846,991